Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2
Introduction 11
2.1 What Is This Report About? 11
3 Definitions of
Markets Covered in This Report 12
3.1 Drug delivery devices 12
3.2
Needle-free Injections 12
3.3 Inhalation Systems 12
3.3.1 Metered Dose
Inhaler 12
3.3.2 Dry powder inhaler 12
3.4 Infusion Systems 12
3.4.1 Infusion pumps 12
3.4.2 Syringe pumps 13
3.4.3 Disposable
Infusion sets 13
4 Healthcare Sector Review 14
4.1 Healthcare Sector
14
4.2 Healthcare Expenditure 14
4.3 Healthcare Infrastructure 18
4.3.1 Healthcare Personnel Data 18
4.3.2 Healthcare Facilities Data 20
4.4 Healthcare Policy 25
5 Regulation System 26
5.1 Regulation System
26
5.2 Medical Equipment Approval Process 26
5.2.1 Classification of
Medical Devices 26
5.3 Conformity Assessment Process 35
5.3.1 Class I
devices 35
5.3.2 Class IIa devices 36
5.3.3 Class IIb devices 37
5.3.4 Class III devices 38
5.4 Post Market Surveillance 39
6 Pricing
and Reimbursement 40
6.1 SHI 40
6.1.1 Private Health Insurance 40
6.1.2 Diagnosis Related Groups (DRG) 40
7 Distribution Structure 41
8
Drug Delivery Devices In Germany 42
8.1 Drug Delivery Devices Cross
Country Comparison, Revenue ($ mn), 2000-2015 42
8.2 Drug Delivery
Devices, Germany, Overall Revenue ($ mn), 2000-2015 43
8.3 Drug Delivery
Devices, Germany, Category Volume (Units), 2000-2015 47
8.4 Drug Delivery
Devices, Germany, Company Share (2006-2007) 50
9 Infusion Systems In
Germany 51
9.1 Infusion Systems Overall Revenue (2000-2015) 51
9.2
Infusion Systems Overall Volume (2000-2015) 53
9.3 Infusion Systems
Average Price (2000-2015) 54
9.4 Infusion Systems Distribution Share
(2007-2008) 55
9.5 Infusion Systems, Germany, Company Share (2006-2007)
56
10 Inhalation Systems In Germany 57
10.1 Inhalation Systems Overall
Revenue (2000-2015) 57
10.2 Inhalation Systems Overall Volume (2000-2015)
59
10.3 Inhalation Systems Average Price (2000-2015) 61
10.4
Inhalation Systems Distribution Share (2007-2008) 61
10.5 Inhalation
Systems, Germany, Company Share (2006-2007) 62
11 Needle Free Injections
In Germany 63
11.1 Needle Free Injections Overall Revenue (2000-2015)
63
11.2 Needle Free Injections Overall Volume (2000-2015) 65
11.3
Needle Free Injections Average Price (2000-2015) 67
11.4 Needle Free
Injections Distribution Share (2007-2008) 67
11.5 Needle Free Injections,
Germany, Company Share (2006-2007) 68
12 Overview of Key Companies in
Germany Drug Delivery Devices Market 69
12.1 AstraZeneca PLC Company
Profile 69
12.1.1 Company Overview 69
12.2 Boehringer Ingelheim GmbH
Company Profile 70
12.2.1 Company Overview 70
12.2.2 Value Chain
Analysis 71
12.2.2.1 Manufacturing 71
12.2.2.2 Product Development
72
12.2.2.3 Sales and Marketing 72
12.3 GlaxoSmithKline plc Company
Profile 73
12.3.1 Company Overview 73
12.4 Baxter International Inc.
Company Profile 73
12.4.1 Company Overview 73
12.4.2 Value Chain
Analysis 74
12.4.2.1 Manufacturing 74
12.4.2.2 Product Development
74
12.4.2.3 Sales and Marketing 75
12.5 Novartis AG 76
12.5.1
Company Overview 76
12.6 Fresenius SE 76
12.6.1 Company Overview
76
12.7 Cardinal Health, Inc. Company Profile 77
12.7.1 Company
Overview 77
12.7.2 Value Chain Analysis 77
12.7.2.1 Manufacturing
78
12.7.2.2 Product Development 78
12.7.2.3 Sales and Marketing 79
12.8 Hospira, Inc. Company Profile 80
12.8.1 Company Overview 80
12.8.2 Value Chain Analysis 80
12.8.2.1 Manufacturing 81
12.8.2.2
Product Development 81
12.8.2.3 Research and Development 82
12.8.2.4
Sales and Marketing 82
12.8.3 Hospira, Inc. Pipeline Products 83
12.8.3.1 Hospira, Inc. Pipeline Products by Equipment Type 83
12.8.3.2
Hospira, Inc. Pipeline Products by Development Stage 83
12.8.3.3 Hospira,
Inc. Pipeline Products by Therapy Area 83
12.9 Smiths Medical Company
Profile 84
12.9.1 Company Overview 84
12.9.2 Value Chain Analysis
84
12.9.2.1 Manufacturing 85
12.9.2.2 Product Development 85
12.9.2.3 Sales and Marketing 85
12.10 Consort Medical plc Company Profile
87
12.10.1 Company Overview 87
12.10.2 Value Chain Analysis 87
12.10.2.1 Manufacturing 88
12.10.2.2 Product Development 88
12.10.2.3
Sales and Marketing 88
12.10.3 Consort Medical plc Pipeline Products
89
12.10.3.1 Consort Medical plc Pipeline Products By Equipment Type
89
12.10.3.2 Consort Medical plc Pipeline Products By Development Stage
89
12.10.3.3 Consort Medical plc Pipeline Products By Therapy Area 89
12.11 Bioject Medical Technologies Inc. 90
12.11.1 Company Overview 90
12.11.2 Value Chain Analysis 90
12.11.2.1 Manufacturing 91
12.11.2.2
Product Development 91
12.11.2.3 Sales and Marketing 92
13 Recent
Developments 93
13.1 Product News 93
13.1.1 Oct 07, 2008: PARI Pharma
Unveils Closed System Using eFlow Technology At Medical Plastics Conference
93
13.1.2 Sep 24, 2008: Bayer HealthCare Pharmaceuticals Launching New
Needle For Betaseron 93
14 Appendix 94
14.1 Global Markets Direct
Research Methodology 94
14.2 Coverage 95
14.3 Secondary Research
95
14.4 Primary Research 96
14.5 Models 96
14.6 Forecasts 97
14.7 Expert Panel Validation 97
14.8 Currency Conversion 98
14.9
Contact Us 99
14.10 Disclaimer 99
1.1 List of Tables
Table 1:
Healthcare Personnel by Region in Germany, 2004 18
Table 2: Doctors by
Specialty in Germany, 2000-2004 19
Table 3: Hospitals by Region in
Germany, 2004 20
Table 4: Hospital Beds by Region in Germany, 2004 21
Table 5: Rehabilitation Centers by Region in Germany, 2004 22
Table 6:
Rehabilitation Center Beds by Region in Germany, 2004 23
Table 7:
Discharges by Diagnosis in Germany, 2004 24
Table 8: Drug Delivery
Devices Cross Country Comparison, Revenue ($ mn), 2000-2015 42
Table 9:
Drug Delivery Devices, Germany, Overall Revenue ($ mn), 2000-2015 43
Table 10: Drug Delivery Devices, Germany, Portfolio Analysis, 2000-2015 44
Table 11: Drug Delivery Devices, Germany, Overall Revenue ($ mn),
Historic, 2000-2008 45
Table 12: Drug Delivery Devices, Germany,
Overall Revenue ($ mn), Forecast, 2008-2015 46
Table 13: Drug
Delivery Devices, Germany, Category Volume (Units), 2000-2015 47
Table 14:
Drug Delivery Devices, Germany, Category Volume (Units), Historic,
2000-2008 48
Table 15: Drug Delivery Devices, Germany, Category
Volume (Units), Forecast, 2008-2015 49
Table 16: Drug Delivery
Devices, Germany, Company Share by Revenue ($ mn), 2006-2007 50
Table 17:
Infusion Systems, Germany, Revenue ($ mn) by Segment, Historic, 2000-2008
51
Table 18: Infusion Systems, Germany, Revenue ($ mn) by Segment,
Forecast, 2008-2015 52
Table 19: Infusion Systems, Germany, Volume
(Units) by Segment, Historic, 2000-2008 53
Table 20: Infusion
Systems, Germany, Volume (Units) by Segment, Forecast, 2008-2015 53
Table
21: Infusion Systems, Germany, Average Price ($), Historic, 2000-2008
54
Table 22: Infusion Systems, Germany, Average Price ($), Forecast,,
2008-2015 54
Table 23: Infusion Systems, Germany, Distribution Share
by Revenue ($mn), 2007-2008 55
Table 24: Infusion Systems, Germany,
Company Share by Revenue ($ mn), 2006-2007 56
Table 25: Inhalation
Systems, Germany, Revenue ($ mn) by Segment, Historic, 2000-2008 57
Table
26: Inhalation Systems, Germany, Revenue ($ mn) by Segment, Forecast,
2008-2015 58
Table 27: Inhalation Systems, Germany, Volume (Units) by
Segment, Historic, 2000-2008 59
Table 28: Inhalation Systems,
Germany, Volume (Units) by Segment, Forecast, 2008-2015 60
Table 29:
Inhalation Systems, Germany, Average Price ($), Historic, 2000-2008 61
Table 30: Inhalation Systems, Germany, Average Price ($), Forecast,,
2008-2015 61
Table 31: Inhalation Systems, Germany, Distribution
Share by Revenue ($mn), 2007-2008 61
Table 32: Inhalation Systems,
Germany, Company Share by Revenue ($ mn), 2006-2007 62
Table 33:
Needle Free Injections, Germany, Revenue ($ mn), Historic, 2000-2008 63
Table 34: Needle Free Injections, Germany, Revenue ($ mn), Forecast,
2008-2015 64
Table 35: Needle Free Injections, Germany, Volume
(Units), Historic, 2000-2008 65
Table 36: Needle Free Injections,
Germany, Volume (Units), Forecast, 2008-2015 66
Table 37: Needle Free
Injections, Germany, Average Price ($), Historic, 2000-2008 67
Table 38:
Needle Free Injections, Germany, Average Price ($), Forecast,, 2008-2015
67
Table 39: Needle Free Injections, Germany, Distribution Share by
Revenue ($mn), 2007-2008 67
Table 40: Needle Free Injections,
Germany, Company Share by Revenue ($ mn), 2006-2007 68
Table 41:
Hospira, Inc. Pipeline Products by Equipment Type 83
Table 42:
Hospira, Inc. Pipeline Products By Development Stage 83
Table 43:
Hospira, Inc. Pipeline Products By Therapy Area 83
Table 44: Consort
Medical plc Pipeline Products by Equipment Type 89
Table 45: Consort
Medical plc Pipeline Products By Development Stage 89
Table 46:
Consort Medical plc Pipeline Products By Therapy Area 89
Table 47: USD
to Local Currency, Average Exchange Rate 2008 98
1.2 List of
Figures
Figure 1: Healthcare Structure in Germany, 2000 - 2006 15
Figure 2: Healthcare Expenditure Sources in Germany, 2003 16
Figure 3:
Healthcare Financing Framework in Germany, 2007 17
Figure 4: Flowchart for
Classification of Non-invasive Devices in Germany, 2007 27
Figure 5:
Flowchart for Classification of Invasive Devices in Germany, 2007 28
Figure 6: Flowchart for Classification of Invasive Devices in Germany, 2007
29
Figure 7: Classification of Invasive Devices in Germany, 2007 30
Figure 8: Classification of Invasive Devices in Germany, 2007 31
Figure 9:
Flowchart for Classification of Active Devices in Germany, 2007 32
Figure
10: Flowchart for Classification of Active Devices in Germany, 2007 33
Figure 11: Flowchart for Classification of Devices except Non-invasive,
Invasive and Active Devices in Germany, 2007 34
Figure 12: Conformity
Assessment of Class-I Medical Devices in Germany, 2007 35
Figure 13:
Conformity Assessment of Class-IIa Medical Devices in Germany, 2007 36
Figure 14: Conformity Assessment of Class-IIb Medical Devices in Germany, 2007
37
Figure 15: Conformity Assessment of Class-III Medical Devices in
Germany, 2007 38
Figure 16: Drug Delivery Devices Cross Country
Comparison, Revenue ($ mn), 2000-2015 42
Figure 17: Drug Delivery
Devices, Germany, Overall Revenue ($ mn), 2000-2015 43
Figure 18:
Drug Delivery Devices, Germany, Portfolio Analysis, 2000-2015 44
Figure
19: Drug Delivery Devices, Germany, Overall Revenue ($ mn), Historic,
2000-2008 45
Figure 20: Drug Delivery Devices, Germany, Overall
Revenue ($ mn), Forecast, 2008-2015 46
Figure 21: Drug Delivery
Devices, Germany, Category Volume (Units), 2000-2015 47
Figure 22:
Drug Delivery Devices, Germany, Category Volume (Units), Historic, 2000-2008
48
Figure 23: Drug Delivery Devices, Germany, Category Volume
(Units), Forecast, 2008-2015 49
Figure 24: Drug Delivery Devices,
Germany, Company Share (%), 2007 50
Figure 25: Infusion Systems,
Germany, Revenue ($ mn) by Segment, Historic, 2000-2008 51
Figure 26:
Infusion Systems, Germany, Revenue ($ mn) by Segment, Forecast, 2008-2015
52
Figure 27: Infusion Systems, Germany, Company Share (%), 2007
56
Figure 28: Inhalation Systems, Germany, Revenue ($ mn) by Segment,
Historic, 2000-2008 57
Figure 29: Inhalation Systems, Germany,
Revenue ($ mn) by Segment, Forecast, 2008-2015 58
Figure 30:
Inhalation Systems, Germany, Volume (Units) by Segment, Historic, 2000-2008
59
Figure 31: Inhalation Systems, Germany, Volume (Units) by Segment,
Forecast, 2008-2015 60
Figure 32: Inhalation Systems, Germany,
Company Share (%), 2007 62
Figure 33: Needle Free Injections,
Germany, Revenue ($ mn), Historic, 2000-2008 63
Figure 34: Needle
Free Injections, Germany, Revenue ($ mn), Forecast, 2008-2015 64
Figure
35: Needle Free Injections, Germany, Volume (Units), Historic, 2000-2008
65
Figure 36: Needle Free Injections, Germany, Volume (Units),
Forecast, 2008-2015 66
Figure 37: Needle Free Injections, Germany,
Company Share (%), 2007 68
Figure 38: Boehringer Ingelheim GmbH Value
Chain Analysis 71
Figure 39: Baxter International Inc. Value Chain
Analysis 74
Figure 40: Cardinal Health, Inc. Value Chain Analysis
77
Figure 41: Hospira, Inc. Value Chain Analysis 80
Figure 42:
Smiths Medical Value Chain Analysis 84
Figure 43: Consort Medical
plc Value Chain Analysis 87
Figure 44: Bioject Medical Technologies
Inc., Value Chain Analysis 90
Figure 45: Global Markets Direct
Methodology 94
|
|
View Cart
